Celsion
0
0
+€0.00+0% 00:00 Today
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of directed chemotherapies, DNA-mediated immunotherapy, and vaccines. Its lead product candidate is ThermoDox, a liposomal encapsulation of doxorubicin, which is in Phase III clinical trial for the treatment of primary liver cancer. The company is also developing GEN-1, a DNA-based immunotherapeutic product, which is in Phase II clinical trials for the localized treatment of ovarian cancers. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.
Show More
CEO
Mr. Michael H. Tardugno
Employees
27
Country
Germany
ISIN
US15117N5032
Listings
0 Comments
Share your thoughts
FAQs
What is Celsion stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Celsion stocks are traded under the ticker CBOC.STU.
How many employees does Celsion have?▼
As of November 1, 2026, the company has 27 employees.
In which sector is Celsion located?▼
Celsion operates in the Health & Wellness sector.
When did Celsion complete a stock split?▼
The last stock split for Celsion was on March 1, 2022 with a ratio of 1:15.
Where is Celsion headquartered?▼
Celsion is headquartered in Lawrenceville, Germany.